HIV drug market. Market indicators

Nature Reviews Drug Discovery

Volumn 2, Issue 7, 2003, Pages 513-514

  Werber, Yaron ^a  

^a SG Cowen Securities   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; AMPRENAVIR; AMPRENAVIR PHOSPHATE; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; ATAZANAVIR; CD4 IMMUNOGLOBULIN G2; EFAVIRENZ; EMTRICITABINE; ENFUVIRTIDE; INDINAVIR; INTEGRASE INHIBITOR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; MARAVIROC; MONOCLONAL ANTIBODY; NELFINAVIR; NEVIRAPINE; PRO 140; PRODRUG; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; T 1249; TENOFOVIR; TENOFOVIR DISOPROXIL; TNX 355; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

DRUG APPROVAL; DRUG COST; DRUG MARKETING; DRUG POTENCY; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; FOOD AND DRUG ADMINISTRATION; HEALTH HAZARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INCIDENCE; LIPODYSTROPHY; MORTALITY; MULTIDRUG RESISTANCE; NORTH AMERICA; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; UNITED STATES; VIRUS TRANSMISSION; WESTERN EUROPE; ARTICLE; DRUG COMBINATION;

ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; HIV PROTEASE INHIBITORS; HUMANS;

EID: 0037664662     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1135     Document Type: Note

References (2)

1. Byakika-Tusiime, J. et al. Ability to purchase and secure stable therapy are significant predictors of non-adherence to antiretroviral therapy in Kampala, Uganda. 10th Conf. Retroviruses Opportunistic Infect. Oral Abstract 170 (2003).
2. SG Cowen research. HIV physician survey results. (2003).